Hemolytic anemia
Definition
Hemolytic anemia is a condition in which there are not enough red blood cells in the blood, due to the premature destruction of red blood cells. There are a number of specific types of hemolytic anemia, which are described individually.
Alternative Names
Anemia - hemolytic
Causes, incidence, and risk factors
Hemolytic anemia occurs when the bone marrow is unable to increase production to make up for the premature destruction of red blood cells. If the bone marrow is able to keep up with the early destruction, anemia does not occur (sometimes called compensated hemolysis).
There are many types of hemolytic anemia, which are classified by the reason for the premature destruction of red blood cells. The defect may be in the red blood cell itself (intrinsic factor), or outside the red blood cell (extrinsic factors).
Intrinsic factors are often present at birth (hereditary). They include:
- Abnormalities in the proteins that build normal red blood cells
- Differences in the protein inside a red blood cell that carries oxygen (hemoglobin)
Extrinsic factors include:
- Abnormal immune system responses
- Blood clots in small blood vessels
- Certain infections
- Side effects from medications
Types of hemolytic anemia include:
- Hemoglobin SC disease (similar in symptoms to sickle-cell anemia)
- Hemolytic anemia due to G6PD deficiency
- Hereditary elliptocytosis
- Hereditary ovalocytosis
- Hereditary spherocytosis
- Idiopathic autoimmune hemolytic anemia
- Malaria
- Microangiopathic hemolytic anemia (MAHA)
- Non-immune hemolytic anemia caused by chemicals or toxins
- Paroxysmal nocturnal hemoglobinuria (PNH)
- Secondary immune hemolytic anemia
- Sickle-cell anemia
- Thalassemia
- Transfusion of blood from a donor with a different blood type
Symptoms
- Chills
- Dark urine
- Enlarged spleen
- Fatigue
- Pale skin color (pallor)
- Rapid heart rate
- Shortness of breath
- Yellow skin color (jaundice)
Signs and tests
These are tests for red blood cell destruction (hemolysis). Specific tests can identify the types of hemolytic anemia. They are usually performed when hemolysis is suspected or has been determined.
- Absolute reticulocyte count
- Free hemoglobin in the serum or urine
- Hemosiderin in the urine
- Red blood cell count (RBC) and hemoglobin
- Serum haptoglobin levels
- Serum indirect bilirubin levels
- Serum LDH
- Urine and fecal urobilinogen
Directly measuring the red cell life span with radioactive tagging techniques shows a shortened life span.
This disease may also affect the following test results, depending on the specific cause:
- AST
- Coombs' test, direct
- Coombs' test, indirect
- Donath-Landsteiner test
- Febrile or cold agglutinins
- Hematocrit
- Leukocyte alkaline phosphatase
- Peripheral blood smear
- Platelet count
- Protein electrophoresis - serum
- RBC indices
- Serum creatinine
- Serum ferritin
- Serum iron
- Serum potassium level
- Serum uric acid
- TIBC
- White blood count differential
Treatment
Treatment depends on the type and cause of the hemolytic anemia. Folic acid, iron replacement, and corticosteroids may be used. In emergencies, a blood transfusion or removal of the spleen (splenectomy) may be necessary.
Expectations (prognosis)
The outcome depends on the type and cause of hemolytic anemia.
Complications
The complications depend on the specific type of hemolytic anemia. Severe anemia can cause cardiovascular collapse. Severe anemias can aggravate heart disease, lung disease, or cerebrovascular disease.
Calling your health care provider
Call for an appointment with your health care provider if you develop symptoms of hemolytic anemia.
Prevention
There is no known prevention for hemolytic anemia.
References
Schwartz RS. Autoimmune and intravascular hemolytic anemias. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007: chap 164.
Review Date:11/23/2008
Reviewed By:David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.
Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.







E-mail this page to a friend